8.6 Total available funding (item 8.4 + item 8.5) $848,418
8.7 Estimated quarters of funding available (item 8.6 divided by item 8.3) 0.8
8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?
Answer: The Company is actively communicating with its shareholders in relation to a future capital raising and currently believes it can secure funding to continue its operating activities.
8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?
Answer: The Company expects to be able to continue its operations through cost reductions and securing additional funding where required. The availability and timing of funding will be a determining factor for the Company in meeting its objectives, including its focus on advancing the Mabilo Project in the Philippines and the Chanach Project
- Forums
- ASX - By Stock
- RTG
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-3
Featured News
Add RTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.88M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 153019 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 153019 | 0.033 |
1 | 250000 | 0.030 |
2 | 400000 | 0.029 |
1 | 100000 | 0.026 |
2 | 580000 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 200000 | 1 |
0.037 | 3304 | 1 |
0.039 | 50000 | 1 |
0.040 | 150000 | 1 |
0.046 | 350000 | 1 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
RTG (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online